| Cyclophosphamide | Approved Investigational | CASP1 | 834 |
downregulated | Cyclophosphamide results in decreased expression of CASP1 mRNA | 11q22.3 | |
| Cyclophosphamide | Approved Investigational | CASP3 | 836 |
upregulated | Cyclophosphamide results in increased expression of CASP3 mRNA | 4q35.1 | |
| Cyclophosphamide | Approved Investigational | CCR8 | 1237 |
downregulated | Cyclophosphamide results in decreased expression of CCR8 mRNA | 3p22.1 | |
| Cyclophosphamide | Approved Investigational | CD69 | 969 |
downregulated | Cyclophosphamide metabolite results in decreased expression of CD69 mRNA | 12p13.31 | |
| Cyclophosphamide | Approved Investigational | CD84 | 8832 |
upregulated | Cyclophosphamide metabolite results in increased expression of CD84 mRNA | 1q23.3 | |
| Cyclophosphamide | Approved Investigational | CDKN1A | 1026 |
upregulated | Cyclophosphamide results in increased expression of CDKN1A mRNA | 6p21.2 | |
| Cyclophosphamide | Approved Investigational | CEBPB | 1051 |
downregulated | Cyclophosphamide metabolite results in decreased expression of CEBPB mRNA | 20q13.13 | |
| Cyclophosphamide | Approved Investigational | CEL | 1056 |
upregulated | Cyclophosphamide results in increased expression of CEL mRNA | 9q34.13 | |
| Cyclophosphamide | Approved Investigational | CHAC1 | 79094 |
downregulated | Cyclophosphamide metabolite results in decreased expression of CHAC1 mRNA | 15q15.1 | |
| Cyclophosphamide | Approved Investigational | CHAC1 | 79094 |
downregulated | Cyclophosphamide results in decreased expression of CHAC1 mRNA | 15q15.1 | |
| Cyclophosphamide | Approved Investigational | COX7A2 | 1347 |
downregulated | Cyclophosphamide results in decreased expression of COX7A2 mRNA | 6q14.1 | |
| Cyclophosphamide | Approved Investigational | CRABP2 | 1382 |
upregulated | Cyclophosphamide results in increased expression of CRABP2 mRNA | 1q23.1 | |
| Cyclophosphamide | Approved Investigational | CST7 | 8530 |
downregulated | Cyclophosphamide results in decreased expression of CST7 mRNA | 20p11.21 | |
| Cyclophosphamide | Approved Investigational | CSTA | 1475 |
downregulated | Cyclophosphamide metabolite results in decreased expression of CSTA mRNA | 3q21.1 | |
| Cyclophosphamide | Approved Investigational | CTSH | 1512 |
upregulated | Cyclophosphamide results in increased expression of CTSH mRNA | 15q25.1 | |
| Cyclophosphamide | Approved Investigational | CTSL | 1514 |
upregulated | Cyclophosphamide results in increased expression of CTSL mRNA | 9q21.33 | |
| Cyclophosphamide | Approved Investigational | CYP1B1 | 1545 |
downregulated | Cyclophosphamide results in decreased expression of CYP1B1 mRNA | 2p22.2 | |
| Cyclophosphamide | Approved Investigational | CYP2B6 | 1555 |
upregulated | [Cyclophosphamide results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Cyclophosphamide | Approved Investigational | CYP3A4 | 1576 |
upregulated | [Cyclophosphamide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Cyclophosphamide | Approved Investigational | CYP3A4 | 1576 |
upregulated | Cyclophosphamide results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Cyclophosphamide | Approved Investigational | DDIT3 | 1649 |
downregulated | Cyclophosphamide metabolite results in decreased expression of DDIT3 mRNA | 12q13.3 | |
| Cyclophosphamide | Approved Investigational | DLC1 | 10395 |
upregulated | Cyclophosphamide results in increased expression of DLC1 mRNA | 8p22 | |
| Cyclophosphamide | Approved Investigational | DNAJB1 | 3337 |
upregulated | Cyclophosphamide metabolite results in increased expression of DNAJB1 mRNA | 19p13.12 | |
| Cyclophosphamide | Approved Investigational | DNAJB4 | 11080 |
upregulated | Cyclophosphamide metabolite results in increased expression of DNAJB4 mRNA | 1p31.1 | |
| Cyclophosphamide | Approved Investigational | DPYSL4 | 10570 |
upregulated | Cyclophosphamide results in increased expression of DPYSL4 mRNA | 10q26.3 | |